Comment on "Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration".

Stradiotto, E; Ottonelli, G; Romano, M R; La Spina, C

Stradiotto, E; Ottonelli, G; Romano, M R; La Spina, C.

Afiliação

Stradiotto E; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4 Pieve, Emanuele, 20072, Milan, Italy. elisa.stradiotto@humanitas.it.
Ottonelli G; Department of Ophthalmology, Eye Unit Humanitas Gradenigo, Corso Regina Margherita, 8/10, 10153, Turin, Italy. elisa.stradiotto@humanitas.it.
Romano MR; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4 Pieve, Emanuele, 20072, Milan, Italy.
La Spina C; Department of Ophthalmology, Eye Unit Humanitas Gradenigo, Corso Regina Margherita, 8/10, 10153, Turin, Italy.

Graefes Arch Clin Exp Ophthalmol ; 2024 Jun 07.

Article em En | MEDLINE | ID: mdl-38847895

Palavras-chave

Age-related Macular Degeneration; Brolucizumab; Faricimab; Intravitreal injection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Graefes Arch Clin Exp Ophthalmol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google